These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 17387357)

  • 41. The effective duration of analgesia after intrathecal morphine in patients without additional opioid analgesia: a randomized double-blind multicentre study on orthopaedic patients.
    Gehling MH; Luesebrink T; Kulka PJ; Tryba M
    Eur J Anaesthesiol; 2009 Aug; 26(8):683-8. PubMed ID: 19307970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain.
    Grider JS; Harned ME; Etscheidt MA
    Pain Physician; 2011; 14(4):343-51. PubMed ID: 21785477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
    Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
    J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intrathecal hydromorphone for intractable nonmalignant pain: a retrospective study.
    Du Pen S; Du Pen A; Hillyer J
    Pain Med; 2006; 7(1):10-5. PubMed ID: 16533191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristics and adequacy of intravenous morphine infusions in children in a paediatric oncology setting.
    Flogegård H; Ljungman G
    Med Pediatr Oncol; 2003 Apr; 40(4):233-8. PubMed ID: 12555251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of intrathecal dexmedetomidine on spinal morphine analgesia in patients with refractory cancer pain.
    Liu HJ; Gao XZ; Liu XM; Xia M; Li WY; Jin Y
    J Palliat Med; 2014 Jul; 17(7):837-40. PubMed ID: 24702571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pain control with intrathecally and peridurally administered opioids and other drugs.
    Foldes FF
    Anaesthesiol Reanim; 1991; 16(5):287-98. PubMed ID: 1683773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices.
    Stearns L; Boortz-Marx R; Du Pen S; Friehs G; Gordon M; Halyard M; Herbst L; Kiser J
    J Support Oncol; 2005; 3(6):399-408. PubMed ID: 16350425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Continuous intrathecal opiate therapy with a portable drug pump in cancer pain].
    Motsch J; Bleser W; Ismaily AJ; Distler L
    Anasth Intensivther Notfallmed; 1988 Oct; 23(5):271-5. PubMed ID: 2907271
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Patient-controlled morphine analgesia pump].
    Ramé A
    Rev Infirm; 2007 Mar; (128):27-8. PubMed ID: 17438931
    [No Abstract]   [Full Text] [Related]  

  • 51. Long-term intraventricular infusion of morphine for intractable pain in cancer of the head and neck.
    Dennis GC; DeWitty RL
    Neurosurgery; 1990 Mar; 26(3):404-7; discussion 407-8. PubMed ID: 2320208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia.
    Sia AT; Lim Y; Lim EC; Goh RW; Law HY; Landau R; Teo YY; Tan EC
    Anesthesiology; 2008 Sep; 109(3):520-6. PubMed ID: 18719451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low-dose naloxone infusion for the treatment of intractable nausea and vomiting after intrathecal morphine in a parturient.
    Sposito JA; Habib AS
    Int J Obstet Anesth; 2010 Jan; 19(1):119-21. PubMed ID: 19945849
    [No Abstract]   [Full Text] [Related]  

  • 54. [Opioid analgesics in the treatment of non-malignant chronic pain].
    Eriksen J; Clausen TG; Borgbjerg FM
    Ugeskr Laeger; 1994 Jan; 156(5):621-3, 626-7. PubMed ID: 7910424
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A review of intrathecal morphine therapy related granulomas.
    Miele VJ; Price KO; Bloomfield S; Hogg J; Bailes JE
    Eur J Pain; 2006 Apr; 10(3):251-61. PubMed ID: 15964775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of intrathecal morphine analgesia in terminal cancer patients is associated with high levels of excitatory amino acids in the CSF.
    Wong CS; Chang YC; Yeh CC; Huang GS; Cherng CH
    Can J Anaesth; 2002; 49(6):561-5. PubMed ID: 12067866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Strong opioids].
    Furuyama Y; Yamamuro M
    Nihon Rinsho; 2001 Sep; 59(9):1783-8. PubMed ID: 11554052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intrathecal Opioid Therapy for Non-Malignant Chronic Pain: A Long-Term Perspective.
    Kleinmann B; Wolter T
    Neuromodulation; 2017 Oct; 20(7):719-726. PubMed ID: 28560830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incisional continuous fascia iliaca block provides more effective pain relief and fewer side effects than opioids after pelvic osteotomy in children.
    Lako SJ; Steegers MA; van Egmond J; Gardeniers J; Staals LM; van Geffen GJ
    Anesth Analg; 2009 Dec; 109(6):1799-803. PubMed ID: 19923505
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Side effects of opioids during short-term administration: effect of age, gender, and race.
    Cepeda MS; Farrar JT; Baumgarten M; Boston R; Carr DB; Strom BL
    Clin Pharmacol Ther; 2003 Aug; 74(2):102-12. PubMed ID: 12891220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.